Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

2018 ASCO Annual Meeting

1 - 5 Jun 2018
McCormick Place, Chicago, United States of America
ASCO 2018 conference round up
Dr Bishal Gyawali and Will Davies
ASCO 2018 conference round up ( Dr Bishal Gyawali and Will Davies )
24 Jun 2018
Repurposing selective PDE5 inhibitors as anti-cancer agents
Dr Pan Pantziarka - Anticancer Fund, Brussels, Belgium
Repurposing selective PDE5 inhibitors as anti-cancer agents ( Dr Pan Pantziarka -  Anticancer Fund, Brussels, Belgium )
5 Jun 2018
First results of DREAM trial of frontline durvalumab for mesothelioma
Prof Anna Nowak - The University of Western Australia, Perth, Australia
First results of DREAM trial of frontline durvalumab for mesothelioma ( Prof Anna Nowak - The University of Western Australia, Perth, Australia )
5 Jun 2018
Results from the phase I ICONIC trial
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
Results from the phase I ICONIC trial ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )
4 Jun 2018
Chemotherapy plus durvalumab in triple negative breast cancer
Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany
Chemotherapy plus durvalumab in triple negative breast cancer ( Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany )
4 Jun 2018
Phase II results of olaparib and abiraterone for mCRPC
Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK
Phase II results of olaparib and abiraterone for mCRPC ( Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK )
4 Jun 2018
Global treatment pattern variations in HCC
Dr Nahum Mendez-Sanchez - Medica Sur Clinic and Foundation, Mexico City, Mexico
Global treatment pattern variations in HCC ( Dr Nahum Mendez-Sanchez - Medica Sur Clinic and Foundation, Mexico City, Mexico )
4 Jun 2018
Design and interim safety analysis of GeparX trial
Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany
Design and interim safety analysis of GeparX trial ( Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany )
4 Jun 2018
Key developments in non-metastatic and metastatic hormone-sensitive prostate can...
Dr Eleni Efstathiou, Prof Nicholas Mottet, Dr Andrew Armstrong and Prof Maria De...
Key developments in non-metastatic and metastatic hormone-sensitive prostate cancer ( Dr Eleni Efstathiou, Prof Nicholas Mottet, Dr Andrew Armstrong and Prof Maria De Santis )
4 Jun 2018
International cancer control plans
Dr Verna Vanderpuye - Korle Bu Teaching Hospital, Accra, Ghana
International cancer control plans ( Dr Verna Vanderpuye - Korle Bu Teaching Hospital, Accra, Ghana )
4 Jun 2018
Economic impact of NGS in non small cell lung cancer
Dr Nathan Pennell - Cleveland Clinic Cancer Center, Cleveland, USA
Economic impact of NGS in non small cell lung cancer ( Dr Nathan Pennell - Cleveland Clinic Cancer Center, Cleveland, USA )
4 Jun 2018
Subcutaneous daratumumab shows benefit in patients with relapsed or refractory m...
Dr Ajai Chari - Mount Sinai Hospital, New York, USA
Subcutaneous daratumumab shows benefit in patients with relapsed or refractory multiple myeloma ( Dr Ajai Chari - Mount Sinai Hospital, New York, USA )
4 Jun 2018
Avelumab in combinations for lung cancer and update from ALEX study
Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
Avelumab in combinations for lung cancer and update from ALEX study ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )
4 Jun 2018
Updates in melanoma from ASCO 2018
Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands
Updates in melanoma from ASCO 2018 ( Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands )
4 Jun 2018
Novel fusion proteins to target PD-L1 in HPV associated cancers
Dr James Gulley - Center for Cancer Research, Washington, USA
Novel fusion proteins to target PD-L1 in HPV associated cancers ( Dr James Gulley - Center for Cancer Research, Washington, USA )
4 Jun 2018
Daratumumab in combination with carfilzomib and dexamethasone for relapsed multi...
Dr Ajai Chari - Mount Sinai Hospital, New York, USA
Daratumumab in combination with carfilzomib and dexamethasone for relapsed multiple myeloma ( Dr Ajai Chari - Mount Sinai Hospital, New York, USA )
4 Jun 2018
Phase I study results of M7824 for patients with HPV associated cancers
Dr Julius Strauss - Center for Cancer Research, Washington, USA
Phase I study results of M7824 for patients with HPV associated cancers ( Dr Julius Strauss - Center for Cancer Research, Washington, USA )
4 Jun 2018
Phase III results of PROSPECT study for metastatic, castration-resistant prostat...
Dr James Gulley - Center for Cancer Research, Washington, USA
Phase III results of PROSPECT study for metastatic, castration-resistant prostate cancer ( Dr James Gulley - Center for Cancer Research, Washington, USA )
4 Jun 2018
Pancreatic survival improved with trial chemotherapy regimen after surgery
Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
Pancreatic survival improved with trial chemotherapy regimen after surgery ( Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France )
4 Jun 2018
Aspirin combined with acid-reducing medicine offers moderate benefits in patient...
Prof Janusz Jankowski - Royal College of Surgeons in Ireland, Dublin, Republic o...
Aspirin combined with acid-reducing medicine offers moderate benefits in patients with Barrett’s oesophagus ( Prof Janusz Jankowski - Royal College of Surgeons in Ireland, Dublin, Republic of Ireland )
4 Jun 2018
Pre-operative chemotherapy with radiation may help people with pancreatic cancer...
Dr Geertjan van Tienhoven - Academic Medical Center, Amsterdam, Netherlands
Pre-operative chemotherapy with radiation may help people with pancreatic cancer live longer ( Dr Geertjan van Tienhoven - Academic Medical Center, Amsterdam, Netherlands )
4 Jun 2018
Heated abdominal chemotherapy not beneficial in patients with advanced colorecta...
Dr Francois Quenet - Regional Cancer Institute, Montpellier, France
Heated abdominal chemotherapy not beneficial in patients with advanced colorectal cancer ( Dr Francois Quenet - Regional Cancer Institute, Montpellier, France )
4 Jun 2018
Comment: Pancreatic cancer survival extended by over a year with chemotherapy re...
Dr Andrew Epstein and Prof Richard Schilsky
Comment: Pancreatic cancer survival extended by over a year with chemotherapy regimen ( Dr Andrew Epstein and Prof Richard Schilsky )
4 Jun 2018
Comment: Aspirin with acid-reducing medicine reduces chance of oesophageal cance...
Dr Andrew Epstein and Prof Richard Schilsky
Comment: Aspirin with acid-reducing medicine reduces chance of oesophageal cancer in high risk individuals ( Dr Andrew Epstein and Prof Richard Schilsky )
4 Jun 2018
Comment: Improved 2 year survival for pancreatic cancer with pre-operative chemo...
Dr Andrew Epstein, Prof Richard Schilsky and Dr Geertjan van Tienhoven
Comment: Improved 2 year survival for pancreatic cancer with pre-operative chemoradiation ( Dr Andrew Epstein, Prof Richard Schilsky and Dr Geertjan van Tienhoven )
4 Jun 2018
Comment: No benefit of heated abdominal chemotherapy in advanced colorectal canc...
Prof Richard Schilsky, Dr Andrew Epstein and Dr Francois Quenet
Comment: No benefit of heated abdominal chemotherapy in advanced colorectal cancer ( Prof Richard Schilsky, Dr Andrew Epstein and Dr Francois Quenet )
4 Jun 2018
Pancreatic cancer survival extended by over a year with chemotherapy regimen
Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
Pancreatic cancer survival extended by over a year with chemotherapy regimen ( Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France )
4 Jun 2018
Aspirin with acid-reducing medicine reduces chance of oesophageal cancer in high...
Prof Janusz Jankowski - Royal College of Surgeons in Ireland, Dublin, Republic o...
Aspirin with acid-reducing medicine reduces chance of oesophageal cancer in high risk individuals ( Prof Janusz Jankowski - Royal College of Surgeons in Ireland, Dublin, Republic of Ireland )
4 Jun 2018
Improved 2 year survival for pancreatic cancer with pre-operative chemoradiation
Dr Geertjan van Tienhoven - Academic Medical Center, Amsterdam, Netherlands
Improved 2 year survival for pancreatic cancer with pre-operative chemoradiation ( Dr Geertjan van Tienhoven - Academic Medical Center, Amsterdam, Netherlands )
4 Jun 2018
No benefit of heated abdominal chemotherapy in advanced colorectal cancer
Dr Francois Quenet - Regional Cancer Institute, Montpellier, France
No benefit of heated abdominal chemotherapy in advanced colorectal cancer ( Dr Francois Quenet - Regional Cancer Institute, Montpellier, France )
4 Jun 2018
Dabrafenib halts growth of low-grade paediatric glioma
Dr Mark Kieran - Dana Farber Cancer Institue, Boston, USA
Dabrafenib halts growth of low-grade paediatric glioma ( Dr Mark Kieran - Dana Farber Cancer Institue, Boston, USA )
4 Jun 2018
ASCO 2018: Novel treatment strategies in prostate cancer therapeutics
Prof Karim Fizazi and Dr Neal Shore
ASCO 2018: Novel treatment strategies in prostate cancer therapeutics ( Prof Karim Fizazi and Dr Neal Shore )
4 Jun 2018
ASCO 2018: Latest developments in non-metastatic and metastatic castration-resis...
Dr Neal Shore, Dr Simon Chowdhury, Prof Matthew Smith and Prof Boris Hadaschik
ASCO 2018: Latest developments in non-metastatic and metastatic castration-resistant prostate cancer ( Dr Neal Shore, Dr Simon Chowdhury, Prof Matthew Smith and Prof Boris Hadaschik )
3 Jun 2018
Finding appropriate doses for HER2 positive breast cancers
Dr Mariana Chavez-MacGregor - MD Anderson Cancer Center, Houston, USA
Finding appropriate doses for HER2 positive breast cancers ( Dr Mariana Chavez-MacGregor - MD Anderson Cancer Center, Houston, USA )
3 Jun 2018
Updates in targeted therapy for melanoma
Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany
Updates in targeted therapy for melanoma ( Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany )
3 Jun 2018
Education, collaboration and communication in global cancer control
Dr Susannah Stanway - Royal Marsden NHS Foundation Trust, London, UK
Education, collaboration and communication in global cancer control ( Dr Susannah Stanway - Royal Marsden NHS Foundation Trust, London, UK )
3 Jun 2018
Health related quality of life findings from COMBI-AD
Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany
Health related quality of life findings from COMBI-AD ( Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany )
3 Jun 2018
Developing a survivin vaccine for glioblastoma
Dr Michael Ciesielski - Roswell Park Comprehensive Cancer Center, Buffalo, USA
Developing a survivin vaccine for glioblastoma ( Dr Michael Ciesielski - Roswell Park Comprehensive Cancer Center, Buffalo, USA )
3 Jun 2018
Early results from a 3rd gen EGFR-TKI in advanced NSCLC
Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, the Republic of Korea
Early results from a 3rd gen EGFR-TKI in advanced NSCLC ( Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, the Republic of Korea )
3 Jun 2018
New pathways in pancreatic cancer
Dr Federico Sanchez - Aurora Sheboygan Memorial Medical Center, Sheboygan, USA
New pathways in pancreatic cancer ( Dr Federico Sanchez - Aurora Sheboygan Memorial Medical Center, Sheboygan, USA )
3 Jun 2018
OPTIMISMM trial for refractory multiple myeloma
Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA
OPTIMISMM trial for refractory multiple myeloma ( Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA )
3 Jun 2018
Treatment updates in Merkel cell carcinoma
Dr Paul Nghiem - University of Washington, Seattle, USA
Treatment updates in Merkel cell carcinoma ( Dr Paul Nghiem - University of Washington, Seattle, USA )
3 Jun 2018
Results from the LILAC study of ABP 980 with trastuzumab for HER2 early breast ...
Dr Hans-Christian Kolberg - Marienhospital Bottrop, Bottrop, Germany
Results from the LILAC study of ABP 980 with trastuzumab for HER2  early breast cancer ( Dr Hans-Christian Kolberg - Marienhospital Bottrop, Bottrop, Germany )
3 Jun 2018
New treatment markers for myeloma
Dr Jesus San Miguel - Universidad de Navarra, Pamplona, Spain
New treatment markers for myeloma ( Dr Jesus San Miguel - Universidad de Navarra, Pamplona, Spain )
3 Jun 2018
Most breast cancer patients could avoid chemo with use of genetic testing
Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA
Most breast cancer patients could avoid chemo with use of genetic testing ( Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA )
3 Jun 2018
Pembrolizumab works better than chemotherapy alone as initial treatment for NSCL...
Dr Gilberto Lopes - Sylvester Comprehensive Cancer Center, Miami, USA
Pembrolizumab works better than chemotherapy alone as initial treatment for NSCLC ( Dr Gilberto Lopes - Sylvester Comprehensive Cancer Center, Miami, USA )
3 Jun 2018
Maintenance chemotherapy extends life for children with rare rhabdomyosarcoma
Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy
Maintenance chemotherapy extends life for children with rare rhabdomyosarcoma ( Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy )
3 Jun 2018
Sunitinib with or without surgery for metastatic renal cell carcinoma
Prof Arnaud Mejean - Paris Descartes University, Paris, France
Sunitinib with or without surgery for metastatic renal cell carcinoma ( Prof Arnaud Mejean - Paris Descartes University, Paris, France )
3 Jun 2018
Comment: Genetic testing of early breast tumours could allow patients to go with...
Dr Harold Burstein & Prof Richard Schilsky
Comment: Genetic testing of early breast tumours could allow patients to go without chemo ( Dr Harold Burstein & Prof Richard Schilsky )
3 Jun 2018
Comment: PD-1 immunotherapy better than chemo alone as first line lung cancer tr...
Dr John Heymach & Prof Richard Schilsky
Comment: PD-1 immunotherapy better than chemo alone as first line lung cancer treatment ( Dr John Heymach & Prof Richard Schilsky )
3 Jun 2018
Comment: Paediatric rhabdomyosarcoma survival extended with maintenance chemothe...
Prof Richard Schilsky & Dr Gianni Bisogno
Comment: Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy ( Prof Richard Schilsky & Dr Gianni Bisogno )
3 Jun 2018
Comment: Kidney surgery may be unneeded in many intermediate-risk patients
Dr Sumanta Pal & Prof Richard Schilsky
Comment: Kidney surgery may be unneeded in many intermediate-risk patients ( Dr Sumanta Pal & Prof Richard Schilsky )
3 Jun 2018
Genetic testing of early breast tumours could allow patients to go without chemo
Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA
Genetic testing of early breast tumours could allow patients to go without chemo ( Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA )
3 Jun 2018
PD-1 immunotherapy better than chemo alone as first line lung cancer treatment
Dr Gilberto Lopes - Oncoclinicas do Brasil, São Paulo, Brazil
PD-1 immunotherapy better than chemo alone as first line lung cancer treatment ( Dr Gilberto Lopes - Oncoclinicas do Brasil, São Paulo, Brazil )
3 Jun 2018
Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy
Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy
Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy ( Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy )
3 Jun 2018
Kidney surgery may be unneeded in many intermediate-risk patients
Prof Arnaud Mejean - Paris Descartes University, Paris, France
Kidney surgery may be unneeded in many intermediate-risk patients ( Prof Arnaud Mejean - Paris Descartes University, Paris, France )
3 Jun 2018
ASCO 2018: Latest in bladder cancer treatments
Prof Thomas Powles & Prof Shahrokh Shariat
ASCO 2018: Latest in bladder cancer treatments ( Prof Thomas Powles & Prof Shahrokh Shariat )
3 Jun 2018
Cancer treatment in the last 6 months of life: when inaction can outperform acti...
Dr Bishal Gyawali - Brigham and Women's Hospital, Boston, USA
Cancer treatment in the last 6 months of life: when inaction can outperform action ( Dr Bishal Gyawali - Brigham and Women's Hospital, Boston, USA )
3 Jun 2018
ASCO 2018: Integrating genomic data throughout treatment for prostate cancer
Prof Kurt Miller and Prof Bertrand Tombal
ASCO 2018: Integrating genomic data throughout treatment for prostate cancer ( Prof Kurt Miller and Prof Bertrand Tombal )
2 Jun 2018
A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER...
Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA
A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers ( Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA )
2 Jun 2018
Zoptarelin no better than doxarubicin for second-line advanced endometrial cance...
Dr David Miller - The University of Texas Southwestern Medical Center
Zoptarelin no better than doxarubicin for second-line advanced endometrial cancer ( Dr David Miller - The University of Texas Southwestern Medical Center )
2 Jun 2018
Improving global breast cancer care
Prof Carlos Barrios - Pontifica Universidade Catolica de Rio Grande do Sul, Braz...
Improving global breast cancer care ( Prof Carlos Barrios - Pontifica Universidade Catolica de Rio Grande do Sul, Brazil )
2 Jun 2018
What will we expect from novel therapies for oesophageal and gastric malignancie...
Prof Ramon De Mello - University of Algarve, Faro, Portugal
What will we expect from novel therapies for oesophageal and gastric malignancies? ( Prof Ramon De Mello - University of Algarve, Faro, Portugal )
2 Jun 2018
Nelarabine in newly diagnosed paediatric T-cell malignancies
Dr Kimberly Dunsmore - University of Virginia School of Medicine, Virginia, USA
Nelarabine in newly diagnosed paediatric T-cell malignancies ( Dr Kimberly Dunsmore - University of Virginia School of Medicine, Virginia, USA )
2 Jun 2018
Immunotherapy trials and hyperprogressive disease
Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain
Immunotherapy trials and hyperprogressive disease ( Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )
2 Jun 2018
First-in-human phase 1 study of TAK-931 for solid tumours
Dr Toshio Shimizu - National Cancer Center Hospital (NCCH), Tokyo, Japan
First-in-human phase 1 study of TAK-931 for solid tumours ( Dr Toshio Shimizu - National Cancer Center Hospital (NCCH), Tokyo, Japan )
2 Jun 2018
Web-mediated follow-up via patient-reported outcomes vs. routine surveillance in...
Dr Fabrice Denis - Jean Bernard Centre, Le Mans, France
Web-mediated follow-up via patient-reported outcomes vs. routine surveillance in lung cancer patients ( Dr Fabrice Denis - Jean Bernard Centre, Le Mans, France )
2 Jun 2018
The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for CL...
Prof William Wierda - MD Anderson Cancer Center, Houston, USA
The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for CLL patients ( Prof William Wierda - MD Anderson Cancer Center, Houston, USA )
2 Jun 2018
Development of blood tests for early lung cancer
Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA
Development of blood tests for early lung cancer ( Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA )
2 Jun 2018
Linking Lynch Syndrome and microsatellite instability in tumours
Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA
Linking Lynch Syndrome and microsatellite instability in tumours ( Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA )
2 Jun 2018
Matching personalised therapies to patients in the IMPACT trial
Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA
Matching personalised therapies to patients in the IMPACT trial ( Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA )
2 Jun 2018
Atezolizumab with chemotherapy improves PFS in squamous NSCLC
Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA
Atezolizumab with chemotherapy improves PFS in squamous NSCLC ( Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA )
2 Jun 2018
Matching mutations in tumours to precision medicine improves survival
Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA
Matching mutations in tumours to precision medicine improves survival ( Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA )
2 Jun 2018
Development of blood tests for early lung cancer
Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA
Development of blood tests for early lung cancer ( Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA )
2 Jun 2018
Genomic study links several new cancers to Lynch Syndrome
Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA
Genomic study links several new cancers to Lynch Syndrome ( Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA )
2 Jun 2018
Taselisib with fulvestrant slows growth of advanced breast cancer
Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA
Taselisib with fulvestrant slows growth of advanced breast cancer ( Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA )
2 Jun 2018
Atezolizumab with chemotherapy improves PFS in squamous NSCLC
Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA
Atezolizumab with chemotherapy improves PFS in squamous NSCLC ( Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA )
2 Jun 2018